Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Diagnostics (Basel, Switzerland)
|
April 14, 2026
Collaborative Robotic Systems for Pre-Analytical Processing of Biological Specimens in a Medical Laboratory
Andrey G Komarov, Pavel O Bochkov, Arkadiy S Goldberg, et al.
The Journal of Antimicrobial Chemotherapy
|
February 8, 2022
Comparative polymyxin B pharmacokinetics in patients receiving extracorporeal membrane oxygenation
Yury A Surovoy, Maksim A Burkin, Inna A Galvidis, et al.
Journal of Personalized Medicine
|
August 27, 2025
Genetic Modulation of Silodosin Exposure and Efficacy: The Role of CYP3A4, CYP3A5, and UGT2B7 Polymorphisms in Benign Prostatic Hyperplasia Management
Shokhrukh P Abdullaev, Maksim N Shatokhin, Pavel O Bochkov, et al.
Genes
|
October 29, 2025
Impact of Xenobiotic Detoxification Gene Polymorphisms on Steady-State Plasma Concentrations of Apixaban and the Development of Hemorrhagic Complications in Older Patients with Non-Valvular Atrial Fibrillation
Andrey P Kondrakhin, Sherzod P Abdullaev, Ivan V Sychev, et al.
Free Radical Biology & Medicine
|
August 13, 2023
Cytochrome P450 3A4 activity and genetic variants as predictors of liver failure in patients with obstructive jaundice
Sergey S Lebedev, Mikhail M Tavobilov, Alexey A Karpov, et al.
Drug Metabolism and Personalized Therapy
|
June 29, 2024
The impact of <i>ABCB1</i>, <i>CYP3A4</i> and <i>CYP3A5</i> gene polymorphisms on apixaban trough concentration and bleeding risk in patients with atrial fibrillation
Alena I Skripka, Pavel M Krupenin, Olga N Kozhanova, et al.
Drug Metabolism and Personalized Therapy
|
August 14, 2021
MicroRNAs as novel biomarkers for rivaroxaban therapeutic drug monitoring
Eric Rytkin, Irina V Bure, Pavel O Bochkov, et al.
Drug Metabolism and Personalized Therapy
|
April 6, 2022
MicroRNAs as novel biomarkers for rivaroxaban therapeutic drug monitoring
Eric Rytkin, Irina V Bure, Pavel O Bochkov, et al.
Science Progress
|
November 28, 2025
Exome-wide association study of bleeding events in patients receiving direct oral anticoagulants
Dmitry A Sychev, Anastasiia A Buianova, Sherzod P Abdullaev, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Diagnostics (Basel, Switzerland)
|
April 14, 2026
Collaborative Robotic Systems for Pre-Analytical Processing of Biological Specimens in a Medical Laboratory
Andrey G Komarov, Pavel O Bochkov, Arkadiy S Goldberg, et al.
The Journal of Antimicrobial Chemotherapy
|
February 8, 2022
Comparative polymyxin B pharmacokinetics in patients receiving extracorporeal membrane oxygenation
Yury A Surovoy, Maksim A Burkin, Inna A Galvidis, et al.
Journal of Personalized Medicine
|
August 27, 2025
Genetic Modulation of Silodosin Exposure and Efficacy: The Role of CYP3A4, CYP3A5, and UGT2B7 Polymorphisms in Benign Prostatic Hyperplasia Management
Shokhrukh P Abdullaev, Maksim N Shatokhin, Pavel O Bochkov, et al.
Genes
|
October 29, 2025
Impact of Xenobiotic Detoxification Gene Polymorphisms on Steady-State Plasma Concentrations of Apixaban and the Development of Hemorrhagic Complications in Older Patients with Non-Valvular Atrial Fibrillation
Andrey P Kondrakhin, Sherzod P Abdullaev, Ivan V Sychev, et al.
Free Radical Biology & Medicine
|
August 13, 2023
Cytochrome P450 3A4 activity and genetic variants as predictors of liver failure in patients with obstructive jaundice
Sergey S Lebedev, Mikhail M Tavobilov, Alexey A Karpov, et al.
Drug Metabolism and Personalized Therapy
|
June 29, 2024
The impact of <i>ABCB1</i>, <i>CYP3A4</i> and <i>CYP3A5</i> gene polymorphisms on apixaban trough concentration and bleeding risk in patients with atrial fibrillation
Alena I Skripka, Pavel M Krupenin, Olga N Kozhanova, et al.
Drug Metabolism and Personalized Therapy
|
August 14, 2021
MicroRNAs as novel biomarkers for rivaroxaban therapeutic drug monitoring
Eric Rytkin, Irina V Bure, Pavel O Bochkov, et al.
Drug Metabolism and Personalized Therapy
|
April 6, 2022
MicroRNAs as novel biomarkers for rivaroxaban therapeutic drug monitoring
Eric Rytkin, Irina V Bure, Pavel O Bochkov, et al.
Science Progress
|
November 28, 2025
Exome-wide association study of bleeding events in patients receiving direct oral anticoagulants
Dmitry A Sychev, Anastasiia A Buianova, Sherzod P Abdullaev, et al.
Page
of 1